Spiriva Respimat(tiotropium bromide)

COPD — long-term once-daily maintenance; reduces COPD flare-ups. Not for sudden symptoms or asthma.

1 DTP program

From As little as $35/mo

1 platform

FDA-Approved Indications

Long-term maintenance of bronchospasm in COPDMaintenance treatment of asthma in patients ≥6 years

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

via Boehringer Ingelheim Direct · Boehringer Ingelheim

As little as $35/mo

Savings card: $35/mo (commercial insured or uninsured). Cash self-pay: $35/mo. Free shipping. No expiry stated.

Eligibility

Valid Rx required. US patient. No income requirement. Government-funded program patients excluded from savings card. FSA/HSA accepted.

Last verified: Mar 2026

Not sure which Spiriva Respimat program fits your situation?